Morton G - Search Results

1

Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?

Correa RJM, Morton G, Chung HT, Tseng CL, Cheung P, Chu W, Liu SK, McGuffin M, Shahid A, Davidson M, Ravi A, Helou J, Alayed Y, Zhang L, Mamedov A, Loblaw A. Correa RJM, et al. Among authors: morton g. Radiother Oncol. 2022 Apr;169:51-56. doi: 10.1016/j.radonc.2022.02.007. Epub 2022 Feb 10. Radiother Oncol. 2022. PMID: 35151715

2

Early prostate cancer.

Morton GC. Morton GC. Curr Probl Cancer. 2000 Jan-Feb;24(1):5-51. doi: 10.1016/s0147-0272(00)90007-2. Curr Probl Cancer. 2000. PMID: 10749454 Review. No abstract available.

3

The role of serial transrectal ultrasonography in a 'watchful waiting' protocol for men with localized prostate cancer.

Hruby G, Choo R, Klotz L, Danjoux C, Murphy J, Deboer G, Morton G, Rakovitch E, Szumacher E, Fleshner N. Hruby G, et al. Among authors: morton g. BJU Int. 2001 May;87(7):643-7. doi: 10.1046/j.1464-410x.2001.02133.x. BJU Int. 2001. PMID: 11350404

4

Controversies in prostate cancer radiotherapy: consensus development.

Lukka H, Warde P, Pickles T, Morton G, Brundage M, Souhami L; Canadian GU Radiation Oncologist Group. Lukka H, et al. Among authors: morton g. Can J Urol. 2001 Aug;8(4):1314-22. Can J Urol. 2001. PMID: 11564274 Review.

5

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

Choo R, Klotz L, Danjoux C, Morton GC, DeBoer G, Szumacher E, Fleshner N, Bunting P, Hruby G. Choo R, et al. Among authors: morton gc. J Urol. 2002 Apr;167(4):1664-9. J Urol. 2002. PMID: 11912384

6

The role of serial free/total prostate-specific antigen ratios in a watchful observation protocol for men with localized prostate cancer.

Do V, Choo R, De Boer G, Klotz L, Danjoux C, Morton G, Szumacher E, Fleshner N, Bunting P. Do V, et al. Among authors: morton g. BJU Int. 2002 May;89(7):703-9. doi: 10.1046/j.1464-410x.2002.02737.x. BJU Int. 2002. PMID: 11966628

7

(IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy.

Choo R, Hruby G, Hong J, Bahk E, Hong E, Danjoux C, Morton G, DeBoer G. Choo R, et al. Among authors: morton g. Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):269-76. doi: 10.1016/s0360-3016(02)02730-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 12023129

8

Are serial bone scans useful for the follow-up of clinically localized, low to intermediate grade prostate cancer managed with watchful observation alone?

Yap BK, Choo R, Deboer G, Klotz L, Danjoux C, Morton G. Yap BK, et al. Among authors: morton g. BJU Int. 2003 May;91(7):613-7. doi: 10.1046/j.1464-410x.2003.04169.x. BJU Int. 2003. PMID: 12699470

9

Contemporary management of prostate cancer: a practice survey of Ontario genitourinary radiation oncologists.

Rodrigues G, D'Souza D, Crook J, Malone S, Sathya J, Morton G. Rodrigues G, et al. Among authors: morton g. Radiother Oncol. 2003 Oct;69(1):63-72. doi: 10.1016/s0167-8140(03)00274-3. Radiother Oncol. 2003. PMID: 14597358

10

Comparison of histologic grade between initial and follow-up biopsy in untreated, low to intermediate grade, localized prostate cancer.

Choo R, Do V, Sugar L, Klotz L, Bahk E, Hong E, Danjoux C, Morton G, DeBoer G. Choo R, et al. Among authors: morton g. Can J Urol. 2004 Feb;11(1):2118-24. Can J Urol. 2004. PMID: 15003150

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

570 results

Search Page

Filters